pharma news, views and analysis - pharmaphorum.com

Trending

in News
MSD’s Keytruda plus chemo backed by NICE for lung cancer
August 9, 2019 Share
X
MSD’s Keytruda plus chemo backed by NICE for lung cancer
https://pharmaphorum.com/news/msds-keytruda-plus-chemo-backed-by-nice-for-lung-cancer/
in News
Gilead’s Descovy gets FDA panel OK for PrEP, but not for women
August 8, 2019 Share
X
Gilead’s Descovy gets FDA panel OK for PrEP, but not for women
https://pharmaphorum.com/news/gileads-descovy-gets-fda-panel-ok-for-prep-but-not-for-women/

Latest News

Republican revolt threatens Senate drug pricing bill

Republican revolt threatens Senate drug pricing bill

A bipartisan bill voted through by the Senate Finance Committee last week is under threat from a group

X

Republican revolt threatens Senate drug pricing bill

https://pharmaphorum.com/news/republican-revolt-threatens-senate-drug-pricing-bill/

Allergan pulls breast implants after link to rare cancer

Allergan pulls breast implants after link to rare cancer

Allergan has followed through on an FDA request to carry out a worldwide recall of textured breast implant

X

Allergan pulls breast implants after link to rare cancer

https://pharmaphorum.com/news/allergan-pulls-breast-implants-after-link-to-rare-cancer/

Vertex presses go on its cystic fibrosis triple filing

Vertex presses go on its cystic fibrosis triple filing

Vertex has launched the next phase of its plan for the cystic fibrosis market, filing for approval of

X

Vertex presses go on its cystic fibrosis triple filing

https://pharmaphorum.com/news/vertex-presses-go-on-its-cystic-fibrosis-triple-filing/

Views & analysis

Building our own community for an ultra-rare disease

Building our own community for an ultra-rare disease

Bo Bigelow shares the story of his daughter Tess, who has an ultra-rare genetic disorder with only 51

X

Building our own community for an ultra-rare disease

https://pharmaphorum.com/views-and-analysis/building-our-own-community-for-an-ultra-rare-disease/

Time to build evidence for patient involvement in research

Time to build evidence for patient involvement in research

Patient and public involvement (PPI) may be increasingly seen as the “right thing to do”, but without systematic

X

Time to build evidence for patient involvement in research

https://pharmaphorum.com/views-analysis-patients/time-to-build-evidence-for-patient-involvement-in-research/

Lung cancer’s patient information gap: the pharmaphorum podcast

Lung cancer’s patient information gap: the pharmaphorum podcast

For episode 13 of the pharmaphorum podcast podcast I went to AstraZeneca’s London base to meet Paul Naish,

X

Lung cancer’s patient information gap: the pharmaphorum podcast

https://pharmaphorum.com/podcast/lung-cancers-patient-information-gap

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

X

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

X

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Can simulated datasets unlock the potential of patient data?

Can simulated datasets unlock the potential of patient data?

Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development

X

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

Partner Content

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking

X

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

https://pharmaphorum.com/partner-content/invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/

Pre-Filled Syringes – Chemical Compatibility and Design Strategies

Pre-Filled Syringes – Chemical Compatibility and Design Strategies

Insight in Pre-Filled Syringe Deisgn

X

Pre-Filled Syringes – Chemical Compatibility and Design Strategies

https://pharmaphorum.com/partner-content/pre-filled-syringes-chemical-compatibility-and-design-strategies/

Pre-Filled Syringes East Coast USA the place to debate the future

Future of injectable Drug Delivery

X

Pre-Filled Syringes East Coast USA the place to debate the future

https://pharmaphorum.com/partner-content/pre-filled-syringes-east-coast-usa-the-place-to-debate-the-future/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com